An approach to the synthesis of bruceantin. The synthesis of a tetracyclic intermediate
- 1 December 1989
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Chemistry
- Vol. 67 (12) , 2237-2240
- https://doi.org/10.1139/v89-348
Abstract
An intermediate (20) containing four of the five rings and seven of the ten chiral centers of bruceantin (1) was prepared. In a key reaction, 3-iodo-1-trimethylsilyl-5-hexen-1-yne (9) was found to add chemoselectively and stereoselectively to a dianion. The sequence also includes a selective attack by a sulfinate (17) on the terminal acetylene C-atom of the dianion of a keto acetylene, a concomitant cyclization in which the acetylene acts as an electrophile, and the use of the resulting allyl sulfoxide for the introduction of oxygen functionality by a reductive rearrangement. Keywords: bruceantin, sigmatropic rearrangement, stereoselective alkylation.This publication has 20 references indexed in Scilit:
- Quassinoids. An approach to the BCDE rings of bruceantinThe Journal of Organic Chemistry, 1985
- Acyclic diastereoselection as a synthetic route to quassinoids: a Claisen rearrangement based strategy for bruceantinJournal of the American Chemical Society, 1985
- A synthetic approach to the quassinoidsThe Journal of Organic Chemistry, 1984
- Quassinoids: total synthesis of dl-quassinJournal of the American Chemical Society, 1984
- A new synthetic approach to bruceantin via an intramolecular Diels–Alder reaction: stereoselective construction of the pentacyclic model systemJournal of the Chemical Society, Perkin Transactions 1, 1984
- Quassinoid synthesis via o-quinone Diels-Alder reactionsThe Journal of Organic Chemistry, 1983
- Bruceantin support studies. 5. Rapid access to a highly functionalized tricyclic bruceantin intermediateThe Journal of Organic Chemistry, 1983
- Antitumor Agents XLVIII: Structure-Activity Relationships of Quassinoids as In Vitro Protein Synthesis Inhibitors of P-388 Lymphocytic Leukemia Tumor Cell MetabolismJournal of Pharmaceutical Sciences, 1982
- Structural requirements for biological activity among antileukemic glaucarubolone ester quassinoidsJournal of Medicinal Chemistry, 1976
- MODE OF ACTION OF ANTITUMOR COMPOUND BRUCEANTIN, AN INHIBITOR OF PROTEIN-SYNTHESIS1976